View in EDS

Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer.

Saved in:
Bibliographic Details
Title: Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer.
Authors: Fong L; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California. Lawrence.Fong@ucsf.edu rmiller@corvuspharma.com., Hotson A; Corvus Pharmaceuticals, Burlingame, California., Powderly JD; Carolina BioOncology Institute, Huntersville, North Carolina., Sznol M; Yale University Cancer Center, Yale University, New Haven, Connecticut., Heist RS; Massachusetts General Hospital, Harvard University, Boston, Massachusetts., Choueiri TK; Dana- Farber Cancer Institute, Boston, Massachusetts., George S; Roswell Park Cancer Institute, Buffalo, New York., Hughes BGM; Royal Brisbane Hospital and University of Queensland, Herston, Brisbane, Queensland, Australia., Hellmann MD; Memorial Sloan Kettering Cancer Center, New York, New York., Shepard DR; Cleveland Clinic Foundation, Cleveland, Ohio., Rini BI; Cleveland Clinic Foundation, Cleveland, Ohio., Kummar S; Stanford University School of Medicine, Stanford, California., Weise AM; Karmanos Cancer Institute, Wayne State University, Detroit, Michigan., Riese MJ; Medical College of Wisconsin, Wauwatosa, Wisconsin., Markman B; Monash Health and Monash University, Melbourne, Clayton, Victoria, Australia., Emens LA; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania., Mahadevan D; University of Arizona Cancer Center, Tucson, Arizona., Luke JJ; University of Chicago Medical Center for Care and Discovery, Chicago, Illinois., Laport G; Corvus Pharmaceuticals, Burlingame, California., Brody JD; Icahn School of Medicine at Mount Sinai, New York, New York., Hernandez-Aya L; Washington University Siteman Cancer Center, St Louis, Missouri., Bonomi P; Rush University Medical Center, Chicago, Illinois., Goldman JW; Ronald Reagan UCLA Medical Center, Los Angeles, California., Berim L; University of Nebraska Medical Center, Omaha, Nebraska., Renouf DJ; BC Cancer - Vancouver, Vancouver, British Columbia, Canada., Goodwin RA; The Ottawa Hospital Cancer Centre, Ottawa, Ontario, Canada., Munneke B; Corvus Pharmaceuticals, Burlingame, California., Ho PY; Corvus Pharmaceuticals, Burlingame, California., Hsieh J; Corvus Pharmaceuticals, Burlingame, California., McCaffery I; Corvus Pharmaceuticals, Burlingame, California., Kwei L; Corvus Pharmaceuticals, Burlingame, California., Willingham SB; Corvus Pharmaceuticals, Burlingame, California., Miller RA; Corvus Pharmaceuticals, Burlingame, California. Lawrence.Fong@ucsf.edu rmiller@corvuspharma.com.
Source: Cancer discovery [Cancer Discov] 2020 Jan; Vol. 10 (1), pp. 40-53. Date of Electronic Publication: 2019 Nov 15.
Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 31732494
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Fong+L%22">Fong L</searchLink>; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California. Lawrence.Fong@ucsf.edu rmiller@corvuspharma.com.<br /><searchLink fieldCode="AU" term="%22Hotson+A%22">Hotson A</searchLink>; Corvus Pharmaceuticals, Burlingame, California.<br /><searchLink fieldCode="AU" term="%22Powderly+JD%22">Powderly JD</searchLink>; Carolina BioOncology Institute, Huntersville, North Carolina.<br /><searchLink fieldCode="AU" term="%22Sznol+M%22">Sznol M</searchLink>; Yale University Cancer Center, Yale University, New Haven, Connecticut.<br /><searchLink fieldCode="AU" term="%22Heist+RS%22">Heist RS</searchLink>; Massachusetts General Hospital, Harvard University, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Choueiri+TK%22">Choueiri TK</searchLink>; Dana- Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22George+S%22">George S</searchLink>; Roswell Park Cancer Institute, Buffalo, New York.<br /><searchLink fieldCode="AU" term="%22Hughes+BGM%22">Hughes BGM</searchLink>; Royal Brisbane Hospital and University of Queensland, Herston, Brisbane, Queensland, Australia.<br /><searchLink fieldCode="AU" term="%22Hellmann+MD%22">Hellmann MD</searchLink>; Memorial Sloan Kettering Cancer Center, New York, New York.<br /><searchLink fieldCode="AU" term="%22Shepard+DR%22">Shepard DR</searchLink>; Cleveland Clinic Foundation, Cleveland, Ohio.<br /><searchLink fieldCode="AU" term="%22Rini+BI%22">Rini BI</searchLink>; Cleveland Clinic Foundation, Cleveland, Ohio.<br /><searchLink fieldCode="AU" term="%22Kummar+S%22">Kummar S</searchLink>; Stanford University School of Medicine, Stanford, California.<br /><searchLink fieldCode="AU" term="%22Weise+AM%22">Weise AM</searchLink>; Karmanos Cancer Institute, Wayne State University, Detroit, Michigan.<br /><searchLink fieldCode="AU" term="%22Riese+MJ%22">Riese MJ</searchLink>; Medical College of Wisconsin, Wauwatosa, Wisconsin.<br /><searchLink fieldCode="AU" term="%22Markman+B%22">Markman B</searchLink>; Monash Health and Monash University, Melbourne, Clayton, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Emens+LA%22">Emens LA</searchLink>; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Mahadevan+D%22">Mahadevan D</searchLink>; University of Arizona Cancer Center, Tucson, Arizona.<br /><searchLink fieldCode="AU" term="%22Luke+JJ%22">Luke JJ</searchLink>; University of Chicago Medical Center for Care and Discovery, Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Laport+G%22">Laport G</searchLink>; Corvus Pharmaceuticals, Burlingame, California.<br /><searchLink fieldCode="AU" term="%22Brody+JD%22">Brody JD</searchLink>; Icahn School of Medicine at Mount Sinai, New York, New York.<br /><searchLink fieldCode="AU" term="%22Hernandez-Aya+L%22">Hernandez-Aya L</searchLink>; Washington University Siteman Cancer Center, St Louis, Missouri.<br /><searchLink fieldCode="AU" term="%22Bonomi+P%22">Bonomi P</searchLink>; Rush University Medical Center, Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Goldman+JW%22">Goldman JW</searchLink>; Ronald Reagan UCLA Medical Center, Los Angeles, California.<br /><searchLink fieldCode="AU" term="%22Berim+L%22">Berim L</searchLink>; University of Nebraska Medical Center, Omaha, Nebraska.<br /><searchLink fieldCode="AU" term="%22Renouf+DJ%22">Renouf DJ</searchLink>; BC Cancer - Vancouver, Vancouver, British Columbia, Canada.<br /><searchLink fieldCode="AU" term="%22Goodwin+RA%22">Goodwin RA</searchLink>; The Ottawa Hospital Cancer Centre, Ottawa, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Munneke+B%22">Munneke B</searchLink>; Corvus Pharmaceuticals, Burlingame, California.<br /><searchLink fieldCode="AU" term="%22Ho+PY%22">Ho PY</searchLink>; Corvus Pharmaceuticals, Burlingame, California.<br /><searchLink fieldCode="AU" term="%22Hsieh+J%22">Hsieh J</searchLink>; Corvus Pharmaceuticals, Burlingame, California.<br /><searchLink fieldCode="AU" term="%22McCaffery+I%22">McCaffery I</searchLink>; Corvus Pharmaceuticals, Burlingame, California.<br /><searchLink fieldCode="AU" term="%22Kwei+L%22">Kwei L</searchLink>; Corvus Pharmaceuticals, Burlingame, California.<br /><searchLink fieldCode="AU" term="%22Willingham+SB%22">Willingham SB</searchLink>; Corvus Pharmaceuticals, Burlingame, California.<br /><searchLink fieldCode="AU" term="%22Miller+RA%22">Miller RA</searchLink>; Corvus Pharmaceuticals, Burlingame, California. Lawrence.Fong@ucsf.edu rmiller@corvuspharma.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101561693%22">Cancer discovery</searchLink> [Cancer Discov] 2020 Jan; Vol. 10 (1), pp. 40-53. <i>Date of Electronic Publication: </i>2019 Nov 15.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101561693 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2159-8290 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221598274%22">21598274 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Discov <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31732494
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/2159-8290.CD-19-0980
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 40
    Titles:
      – TitleFull: Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Fong L
      – PersonEntity:
          Name:
            NameFull: Hotson A
      – PersonEntity:
          Name:
            NameFull: Powderly JD
      – PersonEntity:
          Name:
            NameFull: Sznol M
      – PersonEntity:
          Name:
            NameFull: Heist RS
      – PersonEntity:
          Name:
            NameFull: Choueiri TK
      – PersonEntity:
          Name:
            NameFull: George S
      – PersonEntity:
          Name:
            NameFull: Hughes BGM
      – PersonEntity:
          Name:
            NameFull: Hellmann MD
      – PersonEntity:
          Name:
            NameFull: Shepard DR
      – PersonEntity:
          Name:
            NameFull: Rini BI
      – PersonEntity:
          Name:
            NameFull: Kummar S
      – PersonEntity:
          Name:
            NameFull: Weise AM
      – PersonEntity:
          Name:
            NameFull: Riese MJ
      – PersonEntity:
          Name:
            NameFull: Markman B
      – PersonEntity:
          Name:
            NameFull: Emens LA
      – PersonEntity:
          Name:
            NameFull: Mahadevan D
      – PersonEntity:
          Name:
            NameFull: Luke JJ
      – PersonEntity:
          Name:
            NameFull: Laport G
      – PersonEntity:
          Name:
            NameFull: Brody JD
      – PersonEntity:
          Name:
            NameFull: Hernandez-Aya L
      – PersonEntity:
          Name:
            NameFull: Bonomi P
      – PersonEntity:
          Name:
            NameFull: Goldman JW
      – PersonEntity:
          Name:
            NameFull: Berim L
      – PersonEntity:
          Name:
            NameFull: Renouf DJ
      – PersonEntity:
          Name:
            NameFull: Goodwin RA
      – PersonEntity:
          Name:
            NameFull: Munneke B
      – PersonEntity:
          Name:
            NameFull: Ho PY
      – PersonEntity:
          Name:
            NameFull: Hsieh J
      – PersonEntity:
          Name:
            NameFull: McCaffery I
      – PersonEntity:
          Name:
            NameFull: Kwei L
      – PersonEntity:
          Name:
            NameFull: Willingham SB
      – PersonEntity:
          Name:
            NameFull: Miller RA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2020 Jan
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 2159-8290
          Numbering:
            – Type: volume
              Value: 10
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Cancer discovery
              Type: main
ResultId 1